Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1980-04-08
1982-10-05
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
424330, 424316, 424325, A61K 31715
Patent
active
043527930
ABSTRACT:
A composition comprising as the pharmaceutically active ingredient bencyclane fumarate and cyclodextrin.
As compared with prior bencyclane fumarate preparations, this composition can greatly decrease the adverse effects of bencyclane fumarate and, in addition, offers considerable advantages from the viewpoints of method of use and method of production of preparation.
REFERENCES:
patent: 4228160 (1980-10-01), Szejtli et al.
Hennrich and Cramer, J. Am. Chem. Soc., vol. 85, 1/21-1/26, 1965.
Naoki, N., et al., Chem. Pharm. Bull., vol. 26, pp. 3609-3612 (1978).
Szejtli, J., et al., Acta Chimica Academiae Scientiarum Hungarical, vol. 99, pp. 433-446 (1979).
Kurozumi, M., et al., Chem. Pharm. Bull., vol. 23, pp. 3062-3068 (1975).
Fujioka Keiji
Noguchi Takeshi
Noguchi Tetsuo
Sato Shigeji
Yamahira Yoshiya
Hazel Blondel
Sumitomo Chemical Company Limited
LandOfFree
Pharmaceutical composition comprising bencyclane fumarate and cy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising bencyclane fumarate and cy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising bencyclane fumarate and cy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-423077